Sustained unresponsiveness to cashew protein after oral immunotherapy
Part of Immune system & allergy clinical trials.
This study checks if you can stay allergy-free to cashew nuts after completing immunotherapy. It aims to see if your immune system can handle cashew protein without reacting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed allergy to cashew nuts.
- You must have already completed the first phase of immunotherapy and reached the target dose of 1200 mg of cashew protein.
- Your asthma must be well-controlled – no severe asthma or recent hospital stays for asthma.
- You must not be taking certain medications like daily oral steroids, biologics, or specific heart drugs.
- You must not have other serious ongoing conditions like heart disease, epilepsy, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether children who have already completed an oral immunotherapy (desensitization) for sesame allergy can maintain protection after stopping the treatment. The goal is to see if they achieve 'sustained unresponsiveness,' meaning they can eat sesame without an allergic reaction.
This trial tests a new way of giving cashew protein to young children with cashew allergy, gradually increasing the amount to help their bodies stop reacting. The goal is to help your child safely build tolerance to cashew so they may be able to eat it in the future.
This trial tests whether a specially boiled cashew nut can help children with cashew allergy eat cashews without a reaction. It is for children ages 2 to 17 with a confirmed cashew allergy, and it avoids other serious health conditions.
This study tests a treatment that slowly builds tolerance to multiple nut allergens (peanut and tree nuts) in children with allergies. It aims to reduce the risk of severe reactions from accidental exposure.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study compares two ways to manage food allergies in infants: giving tiny amounts of the allergen (oral immunotherapy) versus avoiding the allergen completely. It hopes to find out which approach helps young children outgrow their food allergies more effectively.
Hear when a new Food Allergy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.